These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 29929415)

  • 41. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for Colorectal Cancer Is Associated With Lower Disease Stage: A Population-Based Study.
    Kubisch CH; Crispin A; Mansmann U; Göke B; Kolligs FT
    Clin Gastroenterol Hepatol; 2016 Nov; 14(11):1612-1618.e3. PubMed ID: 27085763
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Passamonti B; Malaspina M; Fraser CG; Tintori B; Carlani A; D'Angelo V; Galeazzi P; Di Dato E; Mariotti L; Bulletti S; D'Amico MR; Gustinucci D; Martinelli N; Spita N; Cesarini E; Rubeca T; Giaimo M; Segnan N; Senore C
    Gut; 2018 Mar; 67(3):485-496. PubMed ID: 27974550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
    Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
    Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.
    Guiriguet C; Pera G; Castells A; Toran P; Grau J; Rivero I; Buron A; Macià F; Vela-Vallespín C; Vilarrubí-Estrella M; Marzo-Castillejo M
    BMC Cancer; 2017 Aug; 17(1):524. PubMed ID: 28784093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test.
    Meester RG; Zauber AG; Doubeni CA; Jensen CD; Quinn VP; Helfand M; Dominitz JA; Levin TR; Corley DA; Lansdorp-Vogelaar I
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1445-1451.e8. PubMed ID: 27211498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme.
    Hol L; Kuipers EJ; van Ballegooijen M; van Vuuren AJ; Reijerink JC; Habbema DJ; van Leerdam ME
    Int J Cancer; 2012 May; 130(9):2096-102. PubMed ID: 21702046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-compliance with colonoscopy after a positive faecal immunochemical test doubles the risk of dying from colorectal cancer.
    Zorzi M; Battagello J; Selby K; Capodaglio G; Baracco S; Rizzato S; Chinellato E; Guzzinati S; Rugge M
    Gut; 2022 Mar; 71(3):561-567. PubMed ID: 33789965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis.
    Toes-Zoutendijk E; de Jonge L; van Iersel CA; Spaander MCW; van Vuuren AJ; van Kemenade F; Ramakers CR; Dekker E; Nagetaal ID; van Leerdam ME; Lansdorp-Vogelaar I
    Gut; 2023 Jul; 72(7):1319-1325. PubMed ID: 37076272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test.
    Zorzi M; Fedeli U; Schievano E; Bovo E; Guzzinati S; Baracco S; Fedato C; Saugo M; Dei Tos AP
    Gut; 2015 May; 64(5):784-90. PubMed ID: 25179811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening and primary prevention of colorectal cancer: a review of sex-specific and site-specific differences.
    Massat NJ; Moss SM; Halloran SP; Duffy SW
    J Med Screen; 2013; 20(3):125-48. PubMed ID: 24197771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study from a public tertiary hospital.
    Lim TZ; Lau J; Wong GJ; Tan KK
    PLoS One; 2021; 16(6):e0250460. PubMed ID: 34086681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L; Swan N; Hughes DJ
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening.
    Kaalby L; Deding U; Al-Najami I; Berg-Beckhoff G; Bjørsum-Meyer T; Laurberg T; Shaukat A; Steele RJC; Koulaouzidis A; Rasmussen M; Kobaek-Larsen M; Baatrup G
    BMC Med; 2023 Jan; 21(1):29. PubMed ID: 36691009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal cancer in a second round after a negative faecal immunochemical test.
    Bujanda L; Sarasqueta C; Castells A; Pellisé M; Cubiella J; Gil I; Cosme A; Arana-Arri E; Mar I; Idigoras I; Portillo I;
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):813-8. PubMed ID: 25856688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tests and investigations for colorectal cancer screening.
    Carroll MR; Seaman HE; Halloran SP
    Clin Biochem; 2014 Jul; 47(10-11):921-39. PubMed ID: 24769265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Similar fecal immunochemical test results in screening and referral colorectal cancer.
    van Turenhout ST; van Rossum LG; Oort FA; Laheij RJ; van Rijn AF; Terhaar sive Droste JS; Fockens P; van der Hulst RW; Bouman AA; Jansen JB; Meijer GA; Dekker E; Mulder CJ
    World J Gastroenterol; 2012 Oct; 18(38):5397-403. PubMed ID: 23082056
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for colorectal cancer in Italy: 2011-2012 survey.
    Zorzi M; Mangone L; Anghinoni E; Baracco S; Borciani E; Caldarella A; Falcini F; Fanetti AC; Ferretti S; Giorgi Rossi P; Michiara M; Randi G; Stracci F; Vicentini M; Zucchetto A; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):108-14. PubMed ID: 26405782
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of the faecal immunochemical test on colorectal cancer survival.
    Gutierrez-Stampa MA; Aguilar V; Sarasqueta C; Cubiella J; Portillo I; Bujanda L
    BMC Cancer; 2020 Jul; 20(1):616. PubMed ID: 32611328
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systematic review and meta-analysis : diagnostic accuracy of faecal immunochemical testing for haemoglobin (FIT) in detecting colorectal cancer for both symptomatic and screening population.
    Stonestreet J; Chandrapalan S; Woolley D; Uthman U; Arasaradnam RP
    Acta Gastroenterol Belg; 2019; 82(2):291-299. PubMed ID: 31314191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.